Danish Medical Marijuana Producer Stenocare To Launch Patented 10mg THC And 10mg CBD Oil In Norway
A publicly traded Danish medical marijuana operator Stenocare announced Monday the approval of its innovative product, Astrum 10-10, for sale in Norway. This milestone paves the way for more patients to access the benefits of medical cannabis treatment. Astrum 10-10 is expected to become available to patients within the next 30 days.
“Our Astrum 10-10 oil was initially approved for sale in Australia and Germany and we are now proud to add Norway to the list,” stated Stenocare CEO Thomas Skovlund Schnegelsberg. “We believe the new Astrum product represents a groundbreaking advancement for the entire medical cannabis industry and Norwegian patients alike. This innovative product directly addresses key challenges with bioavailability in patients, supported by robust data from a pharmacokinetic study in dogs that validates its benefits. With this milestone, Stenocare is firmly positioned as a first-mover in the next generation of …